StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MLCMB.PA$230.00-0.86%
Fair $230.00+0.0%

MLCMB.PA

Compagnie Du Mont-Blanc

Consumer Cyclical / LeisureParis

$230.00

-2.00 (-0.86%)

Fairly Valued+0.0%Fair Value $230.00Fund rank 22/100 · Data gapFallback financials|
SA 49/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-6.5M · quality 33.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 11/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · MLCMB.PALocal privado en este navegador · Compagnie Du Mont-Blanc
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$207M

P/E

10.7x

↓

EV/EBITDA

4.7x

↓

ROE

9.7%

↑

Gross Margin

90.4%

↑

Debt/Equity

0.99

↑
52-Week Range$230
$165$312

TradingView lightweight chart

MLCMB.PA price, volumen y niveles de valoración

Último $230.00Periodo +142.1%
Fair value: $230.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.3%

FCF CAGR

—

FCF margin

-9.2%

FCF / Net income

-0.74x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $155.7M · net income $19.4M · FCF $-14.4M

2022-FY → 2025-FY

Gross margin

90.4%-4.1% pts

Operating margin

18.8%-1.1% pts

Net margin

12.5%-1.3% pts

FCF margin

-9.2%-35.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$155.7M$155.7M$146.0M$127.9M$109.8M
Net Income$19.4M$19.4M$20.1M$16.3M$15.1M
EBITDA$54.6M$54.6M$54.8M$50.6M$47.4M
EPS——22.3118.1016.77
Gross Margin90.4%90.4%91.1%94.7%94.5%
Operating Margin18.8%18.8%18.3%19.7%19.9%
Net Margin12.5%12.5%13.8%12.8%13.8%
Balance Sheet
Debt/Equity0.990.990.990.991.07
Current Ratio2.162.16———
Cash Flow
Free Cash Flow$-14.4M$-14.4M$-5.0M$-6.5M$28.9M
Returns
ROE9.7%9.7%10.6%9.2%9.3%
Valuation
P/E10.6910.695.927.027.16
EV/EBITDA4.684.682.932.652.46
P/B1.031.030.630.650.67
Growth & Yield
Revenue Growth6.7%6.7%14.1%16.4%—
EPS Growth——23.3%7.9%—
Dividend Yield3.7%3.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +40.6%

Total return

+40.6%

Start / end P/E

n/dx → n/dx

EPS bridge

22.31 → n/d

Residual

+36.9%

EPS growthn/d
Multiple reratingn/d
Dividend+3.7%
Residual / FX / buybacks / cross-term+36.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.